As warnings spread that popular diabetes drugs like Byetta may be linked to increased risks of pancreatic and thyroid cancer, patients affected by the side effects are coming forward to ask if they have legal rights for their injuries.
A recent court filing indicates Byetta patients could soon have a special court in which to pursue their claims over Byetta cancer.
Byetta is an injectable medication used twice a day to help those with type-2 diabetes control blood sugar. In 2012, it earned approximately $300 million in sales. Inventor Amylin Pharmaceuticals was purchased by drug giant Bristol-Myers Squibb last year.
However, experts have warned of Byetta’s association with pancreatic cancer and thyroid cancer.
In 2011, researchers at UCLA discovered subjects given Byetta had a 290% higher occurrence of pancreatic cancer and a 473% higher occurrence rate of thyroid cancer by 473%.
This year, the Journal for the American Medical Association also published a study which suggested drugs like Byetta can double the risk of pancreatitis, which is a major risk factor for pancreatic cancer.
Due to the number of patients who have taken the drug, experts predict a substantial number could file a Byetta lawsuit after developing cancer. This month, lawyers asked that Incretin diabetes drug cancer cases be consolidated to a special federal multi-district court in California.
Pancreatic cancer is a severe condition. Anyone affected by this or thyroid cancer after taking Byetta should speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled diabetes drug cancer lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Byetta, or to speak with a lawyer.